Experimental studies of injection agents for peptic ulcer bleeding endoscopic control.
OBJECTIVE
To evaluate haemostatic effectiveness and tissue effects of injected therapy agents used for peptic ulcer bleeding endoscopic control.


METHODS
Bleeding gastric mucosa lesions were produced during operation in 11 heparinised dogs. Bleeding lesions were treated with injections of 1 ml of epinephrine (1:10000), ornipressin (0.2 IU/m]), 98% ethanol, 1% polidocanol, thrombin (1000 U/ml), or fibrin sealant. In another 18 dogs, gastric submucosal injections of tested agents were performed during operations. Dogs were killed 48 h after injections and tissue effects were studied.


RESULTS
The agents tested had similar effectiveness in achieving initial control of experimental bleeding (chi2 = 1.43). Vasoconstrictors caused no tissue injury or thrombosis in vessels after 48 h. Ethanol produced mucosa and submucosa necrosis and thrombosis in vessels. Polidocanol caused mucosa necrosis, submucosa oedema and thrombosis in vessels. Thrombin tissue effects were mucosa oedema, submucosa thrombosis in vessels. Fibrin sealant caused agent insertion between mucosa and submucosa, but no tissue injury or thrombosis in vessels.


CONCLUSIONS
Experiments did not show significant differences between investigated agents in achieving initial bleeding control. The investigated agents, according to the stomach tissue injury they caused in our experiment, would produce series: epinephrine = ornipressin < fibrin sealant < thrombin < polidocanol < ethanol, and according to their effect on vascular thrombosis: epinephrine = ornipressin = fibrin sealant < polidocanol < ethanol < thrombin.
Pundzius
J
J
Surgery Clinic, Kaunas University Hospital, Kaunas, Lithuania.
Jievaltas
M
M
D000818:Animals; D004285:Dogs; D004837:Epinephrine / Q000008:administration & dosage; D000431:Ethanol / Q000008:administration & dosage; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage; D005753:Gastric Mucosa; D016558:Hemostasis, Endoscopic; D006490:Hemostatics / Q000008:administration & dosage; D007267:Injections; D009951:Ornipressin / Q000008:administration & dosage; D010438:Peptic Ulcer Hemorrhage / Q000628:therapy*; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000008:administration & dosage; D012597:Sclerosing Solutions / Q000008:administration & dosage; D013917:Thrombin / Q000008:administration & dosage; D014662:Vasoconstrictor Agents / Q000008:administration & dosage
D015718:Fibrin Tissue Adhesive; D006490:Hemostatics; D012597:Sclerosing Solutions; D014662:Vasoconstrictor Agents; D000077423:Polidocanol; D009951:Ornipressin; D000431:Ethanol; D011092:Polyethylene Glycols; D013917:Thrombin; D004837:Epinephrine